Structural analysis and properties of two novel pharmaceutical salts of letermovir

被引:4
作者
Chai, Yuzhu [1 ,2 ]
Shen, Jianwei [2 ]
Cai, Zhuoer [1 ]
Hua, Xiu-Ni [1 ]
Zhao, Jinhong [2 ]
Xu, Dan [2 ]
Zhu, Chunxia [2 ]
Sun, Baiwang [1 ]
机构
[1] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China
[2] Nanjing Chia Tai Tianqing Pharmaceut Co, Nanjing 211189, Peoples R China
关键词
Novel pharmaceutical; Letermovir; POLYMORPHISM; DISSOLUTION; STATE;
D O I
10.1016/j.molstruc.2023.135414
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Two novel pharmaceutical salts of letermovir (LM) were successfully achieved by a slow reaction in so-lution containing LM with ethylenediamine (EDA) and diisopropylamine (DIPA). In this article, crystal structure, X-ray diffraction, thermal properties, 1 H NMR, 13 C NMR, HPLC analysis, stability and solubility of salt 1 and salt 2 have been discussed. Salt 1 crystalized in R 3 space group and salt 2 crystalized in P 3 2 21 space group. The formation of salt was proved by pKa rule and single crystal determination. From the perspective of crystal structure, for salt 1 and salt 2 , the strong hydrogen bond makes the crystal structure more stable. The weak interaction between molecules is further studied by Hirshfeld surface and 2D-fingerprint plots. Notably, this is the first report of a single crystal structure of LM, which could contribute to the development of corresponding drugs. In addition, salt 1 and salt 2 showed better solu-bility and stability under wet conditions, and had the potential to replace the bulk drug. (c) 2023 Elsevier B.V. All rights reserved.
引用
收藏
页数:6
相关论文
共 11 条
[1]   Towards Physico-Relevant Dissolution Testing: The Importance of Solid-State Analysis in Dissolution [J].
Aaltonen, Jaakko ;
Rades, Thomas .
DISSOLUTION TECHNOLOGIES, 2009, 16 (02) :47-54
[2]   OLEX2: a complete structure solution, refinement and analysis program [J].
Dolomanov, Oleg V. ;
Bourhis, Luc J. ;
Gildea, Richard J. ;
Howard, Judith A. K. ;
Puschmann, Horst .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2009, 42 :339-341
[3]   Refining stability and dissolution rate of amorphous drug formulations [J].
Grohganz, Holger ;
Priemel, Petra A. ;
Lobmann, Korbinian ;
Nielsen, Line Hagner ;
Laitinen, Riikka ;
Mullertz, Anette ;
Van den Mooter, Guy ;
Rades, Thomas .
EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (06) :977-989
[4]   Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12
[5]   CrystalExplorer: A Tool for Displaying Hirshfeld Surfaces and Visualising Intermolecular Interactions in Molecular Crystals [J].
Jayatilaka, Dylan ;
Wolff, Stephen K. ;
Grimwood, Daniel J. ;
McKinnon, Joshua J. ;
Spackman, Mark A. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2006, 62 :S90-S90
[6]   Polymorphism of active pharmaceutical ingredients [J].
Karpinski, PH .
CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) :233-237
[7]   Polymorphism and Crystallization of Active Pharmaceutical Ingredients (APIs) [J].
Lu, Jie ;
Rohani, Sohrab .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (07) :884-905
[8]   Salt screening and characterization for poorly soluble, weak basic compounds: case study albendazole [J].
Paulekuhn, G. S. ;
Dressman, J. B. ;
Saal, C. .
PHARMAZIE, 2013, 68 (07) :555-564
[9]   A short history of SHELX [J].
Sheldrick, George M. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122
[10]   Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review [J].
Tian, Bingren ;
Hua, Shiyao ;
Liu, Jiayue .
CARBOHYDRATE POLYMERS, 2020, 232 (232)